article thumbnail

Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More

Xconomy

Here’s a case study of how fast things can change in biopharma. For a few years, a type of cancer drug called an IDO inhibitor was all the rage, a promising path to expanding the reach of immunotherapy. Major drug makers were dealing, too. Through acquisitions and alliances, they rolled out a spate of large-scale combination trials.

article thumbnail

Should Millennial Entrepreneurs Skip College?

InfoChachkie

I recently spoke to an international group of entrepreneurship professors at San Diego State University’s Lavin Entrepreneurship Center. You can also check out my hands-on startup advice blog HERE. You will have ample time to make a huge impact on the world, after you graduate.”. Get More Than A Degree. Share and Enjoy.

article thumbnail

Interview with Rob Farrow, Chi.mp

socalTECH

You recently moved the headquarters here from Hawaii, can you talk about the decision to move to San Diego? For me, I was born and raised in Hawaii, but have lived in San Diego in the past. San Diego was a selfish decision, because the North County can't be matched in terms of quality of life.